196 related articles for article (PubMed ID: 21468923)
1. Effects of rutaecarpine on the metabolism and urinary excretion of caffeine in rats.
Noh K; Seo YM; Lee SK; Bista SR; Kang MJ; Jahng Y; Kim E; Kang W; Jeong TC
Arch Pharm Res; 2011 Jan; 34(1):119-25. PubMed ID: 21468923
[TBL] [Abstract][Full Text] [Related]
2. Alteration of the pharmacokinetics of theophylline by rutaecarpine, an alkaloid of the medicinal herb Evodia rutaecarpa, in rats.
Ueng YF; Tsai TH; Don MJ; Chen RM; Chen TL
J Pharm Pharmacol; 2005 Feb; 57(2):227-32. PubMed ID: 15720787
[TBL] [Abstract][Full Text] [Related]
3. Effects of Evodia rutaecarpa and rutaecarpine on the pharmacokinetics of caffeine in rats.
Tsai TH; Chang CH; Lin LC
Planta Med; 2005 Jul; 71(7):640-5. PubMed ID: 16041650
[TBL] [Abstract][Full Text] [Related]
4. Induction of cytochrome P450s by rutaecarpine and metabolism of rutaecarpine by cytochrome P450s.
Lee SK; Kim NH; Lee J; Kim DH; Lee ES; Choi HG; Chang HW; Jahng Y; Jeong TC
Planta Med; 2004 Aug; 70(8):753-7. PubMed ID: 15326550
[TBL] [Abstract][Full Text] [Related]
5. The effects of rutaecarpine on the pharmacokinetics of acetaminophen in rats.
Lee SK; Bista SR; Jeong H; Kim DH; Kang MJ; Jahng Y; Jeong TC
Arch Pharm Res; 2007 Dec; 30(12):1629-34. PubMed ID: 18254252
[TBL] [Abstract][Full Text] [Related]
6. Rutaecarpine effects on expression of hepatic phase-1, phase-2 metabolism and transporter genes as a basis of herb-drug interactions.
Zhu QN; Zhang D; Jin T; Wu Q; Liu J; Lu YF
J Ethnopharmacol; 2013 May; 147(1):215-9. PubMed ID: 23510861
[TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetics of caffeine and its metabolites theobromine, paraxanthine and theophylline after inhalation in combination with diacetylmorphine.
Zandvliet AS; Huitema AD; de Jonge ME; den Hoed R; Sparidans RW; Hendriks VM; van den Brink W; van Ree JM; Beijnen JH
Basic Clin Pharmacol Toxicol; 2005 Jan; 96(1):71-9. PubMed ID: 15667599
[TBL] [Abstract][Full Text] [Related]
8. Elimination of rutaecarpine and its metabolites in rat feces and urine measured by liquid chromatography.
Jan WC; Lin LC; Don MJ; Chen CF; Tsai TH
Biomed Chromatogr; 2006 Nov; 20(11):1163-71. PubMed ID: 16799925
[TBL] [Abstract][Full Text] [Related]
9. Effects of major tanshinones isolated from Danshen (Salvia miltiorrhiza) on rat CYP1A2 expression and metabolism of model CYP1A2 probe substrates.
Wang X; Lee WY; Or PM; Yeung JH
Phytomedicine; 2009 Aug; 16(8):712-25. PubMed ID: 19403289
[TBL] [Abstract][Full Text] [Related]
10. Dose independent pharmacokinetics of caffeine after intravenous administration under a chronic food-limited regimen.
Smith C; Ma F; Lau CE
Drug Metabol Drug Interact; 1999; 15(1):83-96. PubMed ID: 10707115
[TBL] [Abstract][Full Text] [Related]
11. Effects of cigarette smoking and carbon monoxide on chlorzoxazone and caffeine metabolism.
Benowitz NL; Peng M; Jacob P
Clin Pharmacol Ther; 2003 Nov; 74(5):468-74. PubMed ID: 14586387
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of theophylline in diabetes mellitus rats: induction of CYP1A2 and CYP2E1 on 1,3-dimethyluric acid formation.
Kim YC; Lee AK; Lee JH; Lee I; Lee DC; Kim SH; Kim SG; Lee MG
Eur J Pharm Sci; 2005 Sep; 26(1):114-23. PubMed ID: 15985363
[TBL] [Abstract][Full Text] [Related]
13. Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1.
Gu L; Gonzalez FJ; Kalow W; Tang BK
Pharmacogenetics; 1992 Apr; 2(2):73-7. PubMed ID: 1302044
[TBL] [Abstract][Full Text] [Related]
14. Effects of the aqueous extract from Salvia miltiorrhiza Bunge on caffeine pharmacokinetics and liver microsomal CYP1A2 activity in humans and rats.
Wang X; Yeung JH
J Pharm Pharmacol; 2010 Aug; 62(8):1077-83. PubMed ID: 20663043
[TBL] [Abstract][Full Text] [Related]
15. Effects of acute renal failure induced by uranyl nitrate on the pharmacokinetics of intravenous theophylline in rats: the role of CYP2E1 induction in 1,3-dimethyluric acid formation.
Yu SY; Chung HC; Kim EJ; Kim SH; Lee I; Kim SG; Lee MG
J Pharm Pharmacol; 2002 Dec; 54(12):1687-92. PubMed ID: 12542900
[TBL] [Abstract][Full Text] [Related]
16. Caffeine and paraxanthine HPLC assay for CYP1A2 phenotype assessment using saliva and plasma.
Perera V; Gross AS; McLachlan AJ
Biomed Chromatogr; 2010 Oct; 24(10):1136-44. PubMed ID: 20853468
[TBL] [Abstract][Full Text] [Related]
17. Effect of venlafaxine on CYP1A2-dependent pharmacokinetics and metabolism of caffeine.
Amchin J; Zarycranski W; Taylor KP; Albano D; Klockowski PM
J Clin Pharmacol; 1999 Mar; 39(3):252-9. PubMed ID: 10073324
[TBL] [Abstract][Full Text] [Related]
18. Induction of NAD(P)H: quinone reductase by rutaecarpine isolated from the fruits of Evodia rutaecarpa in the murine hepatic Hepa-1c1c7 cell line.
Ahn H; Nam JW; Seo EK; Mar W
Planta Med; 2008 Sep; 74(11):1387-90. PubMed ID: 18729042
[TBL] [Abstract][Full Text] [Related]
19. Interaction of pefloxacin and enoxacin with the human cytochrome P450 enzyme CYP1A2.
Kinzig-Schippers M; Fuhr U; Zaigler M; Dammeyer J; Rüsing G; Labedzki A; Bulitta J; Sörgel F
Clin Pharmacol Ther; 1999 Mar; 65(3):262-74. PubMed ID: 10096258
[TBL] [Abstract][Full Text] [Related]
20. Biotransformation of caffeine, paraxanthine, theophylline, and theobromine by polycyclic aromatic hydrocarbon-inducible cytochrome(s) P-450 in human liver microsomes.
Campbell ME; Grant DM; Inaba T; Kalow W
Drug Metab Dispos; 1987; 15(2):237-49. PubMed ID: 2882985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]